CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CALC CALCIMEDICA

未开盘 07-08 16:00:00 EDT

0.9000

-0.0559

-5.85%

盘后0.8880

-0.0120-1.33%

19:12 EDT

最高0.9559	最低0.8700	成交量25.58万
今开0.9373	昨收0.9559	日振幅8.99%
总市值1,417万	流通市值743.75万	总股本1,574万
成交额23.22万	换手率3.09%	流通股本826.39万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":0.9,"timestamp":1783540800000,"preClose":0.9559,"halted":0,"volume":255754,"hourTrading":{"tag":"盘后","latestPrice":0.888,"preClose":0.9,"latestTime":"19:12 EDT","volume":22585,"amount":20613.0733,"timestamp":1783552331414,"change":-0.012,"changeRate":-0.013333,"amplitude":0.089556},"delay":0,"changeRate":-0.058478920389162,"floatShares":8263900,"shares":15743900,"eps":-1.268395,"marketStatus":"未开盘","change":-0.0559,"latestTime":"07-08 16:00:00 EDT","open":0.9373,"high":0.9559,"low":0.87,"amount":232214.96449880002,"amplitude":0.089863,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.268395,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783584000000},"marketStatusCode":0,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":0.9559,"preHourTrading":{"tag":"盘前","latestPrice":0.915,"preClose":0.9559,"latestTime":"09:29 EDT","volume":1386,"amount":1258.3679723999999,"timestamp":1783517399999,"change":-0.0409,"changeRate":-0.042787,"amplitude":0.082331},"postHourTrading":{"tag":"盘后","latestPrice":0.888,"preClose":0.9,"latestTime":"19:12 EDT","volume":22585,"amount":20613.0733,"timestamp":1783552331414,"change":-0.012,"changeRate":-0.013333,"amplitude":0.089556},"volumeRatio":0.405509,"impliedVol":1.8027,"impliedVolPercentile":0.8926},"requestUrl":"/m/hq/s/CALC","defaultTab":"news","newsList":[{"id":"1111601954","title":"Calcimedica推进资金支持Auxora 1B期PAH研究及CM5480新药申请，数据预计2027年中公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1111601954","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111601954?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:02","pubTimestamp":1782298956,"startTime":"0","endTime":"0","summary":"Calcimedica宣布，所获资金将用于支持其候选药物Auxora在肺动脉高压（PAH）领域的1B期临床研究，以及另一款在研药物CM5480的新药临床试验申请（IND）准备工作。\n公司预计，这两项研究的关键数据有望在2027年中期获得。此举标志着Calcimedica在推进其创新疗法管线方面取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152311599","title":"Calcimedica宣布私募融资，筹款约4900万美元以推进肺动脉高压项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1152311599","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152311599?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:02","pubTimestamp":1782298946,"startTime":"0","endTime":"0","summary":"生物技术公司Calcimedica宣布完成一项私募融资，目标筹集资金最高达约4900万美元。此次融资所得将主要用于推进其治疗肺动脉高压的研发项目。\n该公司计划利用这笔资金，加速其针对肺动脉高压的候选药物开发进程。肺动脉高压是一种严重的肺部血管疾病，目前临床治疗选择有限，存在显著的未满足医疗需求。\n通过本轮融资，Calcimedica旨在加强其研发管线，并为后续的临床试验提供资金支持。公司管理层表示，此次融资是推进其核心项目、为患者带来新治疗希望的关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190977051","title":"CalciMedica宣布Auxora临床开发有望推进，此前FDA审查了Kourage试验中期安全性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1190977051","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190977051?lang=zh_cn&edition=full","pubTime":"2026-06-24 19:01","pubTimestamp":1782298909,"startTime":"0","endTime":"0","summary":"CalciMedica公司宣布，其候选药物Auxora的临床开发工作有望继续推进。这一决定是在美国食品药品监督管理局（FDA）完成了对Kourage临床试验中期安全性数据的审查之后作出的。\n此次审查为Auxora的后续开发路径提供了关键支持。公司表示，将根据FDA的反馈，继续推进该药物的临床研究计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163491909","title":"CalciMedica获贷款方展期：仅付息期延至2027年9月30日，到期日延至2029年9月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=1163491909","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163491909?lang=zh_cn&edition=full","pubTime":"2026-06-24 18:53","pubTimestamp":1782298397,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会提交的文件，生物制药公司CalciMedica Inc.已与其贷款方达成协议，对现有贷款条款进行了重要修订。首先，贷款的仅付息期被延长至2027年9月30日。其次，贷款的整体最终到期日也被推迟至2029年9月1日，为公司提供了更长的资金运作和研发窗口。这一财务安排的调整，为CalciMedica推进其临床阶段管道项目，特别是针对急性胰腺炎和哮喘等适应症的CRAC通道抑制剂研发，提供了更为灵活和稳定的资金支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616131175","title":"Calcimedica, Inc.盘中异动 大幅跳水6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616131175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616131175?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:46","pubTimestamp":1772462795,"startTime":"0","endTime":"0","summary":"北京时间2026年03月02日22时46分，Calcimedica, Inc.股票出现异动，股价大幅下跌6.95%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222463597a7af9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030222463597a7af9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRAC","CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145838806","title":"CalciMedica调整财务指引：终止临床试验后，现预期资金可支撑至2026年第四季度——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1145838806","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145838806?lang=zh_cn&edition=full","pubTime":"2026-01-29 06:32","pubTimestamp":1769639544,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件显示，生物制药公司CalciMedica在终止某项临床试验后，已更新其财务运营规划。该公司目前预计，现有资金储备可维持公司运营至2026年第四季度，较先前预期有所延长。\n这一调整反映出CalciMedica在优化研发支出与现金流管理方面取得的进展。临床试验的终止虽可能影响研发进程，但通过重新分配资源，公司成功延长了资金续航能力。此番财务指引的更新，为市场提供了评估其长期财务健康度的新基准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111803537","title":"CalciMedica试验中无死亡病例被认定与研究药物相关","url":"https://stock-news.laohu8.com/highlight/detail?id=1111803537","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111803537?lang=zh_cn&edition=full","pubTime":"2026-01-28 20:09","pubTimestamp":1769602170,"startTime":"0","endTime":"0","summary":"在CalciMedica Inc开展的临床试验中，经研究人员及公司方面评估，未出现任何与研究药物存在关联性的死亡病例。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134177096","title":"CalciMedica宣布根据独立数据监察委员会建议中止急性肾损伤二期Kourage试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1134177096","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134177096?lang=zh_cn&edition=full","pubTime":"2026-01-28 20:02","pubTimestamp":1769601756,"startTime":"0","endTime":"0","summary":"生物制药公司CalciMedica依据独立数据监察委员会的评估建议，决定终止其针对急性肾损伤患者的二期临床试验Kourage研究项目。该决定基于对试验中期数据的全面审查，表明继续研究不符合患者权益最大化原则。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605482965","title":"Calcimedica, Inc.盘中异动 早盘急速拉升6.25%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605482965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605482965?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:58","pubTimestamp":1769007522,"startTime":"0","endTime":"0","summary":"北京时间2026年01月21日22时58分，Calcimedica, Inc.股票出现波动，股价大幅上涨6.25%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Lisata Therapeutics, Inc.、Moolec Science Sa、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Revelation Biosciences, Inc.、Lisata Therapeutics, Inc.较为活跃，换手率分别为878.31%、74.66%、40.02%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Aditxt, Inc.，振幅分别为49.38%、47.55%、35.58%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121225843a44623ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121225843a44623ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRAC","BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602300909","title":"Calcimedica, Inc.盘中异动 早盘股价大涨6.00%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602300909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602300909?lang=zh_cn&edition=full","pubTime":"2026-01-10 00:16","pubTimestamp":1767975414,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日00时16分，Calcimedica, Inc.股票出现波动，股价快速拉升6.00%。截至发稿，该股报5.65美元/股，成交量4.1624万股，换手率0.29%，振幅6.57%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110001655a7081243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260110001655a7081243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","CRAC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518278815","title":"Calcimedica, Inc.盘中异动 股价大跌5.80%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518278815?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613502,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Calcimedica, Inc.股票出现异动，股价大幅下跌5.80%。截至发稿，该股报2.11美元/股，成交量659股，换手率0.00%，振幅6.70%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213142abf2fbfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213142abf2fbfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517198738","title":"Calcimedica, Inc.盘中异动 临近午盘大幅跳水5.32%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517198738?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:58","pubTimestamp":1741280338,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时58分，Calcimedica, Inc.股票出现波动，股价急速下挫5.32%。截至发稿，该股报2.02美元/股，成交量5789股，换手率0.04%，振幅5.63%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005858963c67d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307005858963c67d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517091005","title":"Calcimedica, Inc.盘中异动 股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517091005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517091005?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:45","pubTimestamp":1741185942,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时45分，Calcimedica, Inc.股票出现异动，股价急速下挫5.29%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为486.85%、266.21%、210.17%，振幅较大的相关个股有Nkgen Biotech, Inc.、Silexion Therapeutics Corp、Aditxt, Inc.，振幅分别为40.77%、26.13%、23.90%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224542a260cc92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224542a260cc92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516720166","title":"Calcimedica, Inc.盘中异动 股价大跌11.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516720166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516720166?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098746,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Calcimedica, Inc.股票出现异动，股价急速跳水11.36%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1053.91%、1046.85%、413.90%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Adma Biologics Inc、Ocean Biomedical, Inc.，振幅分别为19.42%、11.75%、10.39%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223226a25f04b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223226a25f04b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514204213","title":"Calcimedica, Inc.盘中异动 快速上涨7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514204213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514204213?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753258,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Calcimedica, Inc.股票出现波动，股价大幅上涨7.29%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为487.98%、246.21%、107.90%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.、Anaptysbio, Inc.，振幅分别为31.14%、24.06%、16.04%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223418abe0eb76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223418abe0eb76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386131","title":"Calcimedica, Inc.盘中异动 股价大涨5.54%报2.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386131?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:52","pubTimestamp":1740667932,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时52分，Calcimedica, Inc.股票出现波动，股价快速拉升5.54%。截至发稿，该股报2.44美元/股，成交量2050股，换手率0.02%，振幅2.38%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272252139632b571&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272252139632b571&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514685066","title":"Calcimedica, Inc.盘中异动 大幅拉升6.05%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514685066?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:37","pubTimestamp":1740587879,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时37分，Calcimedica, Inc.股票出现异动，股价快速上涨6.05%。截至发稿，该股报2.28美元/股，成交量2075股，换手率0.02%，振幅0.00%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270037599631677a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270037599631677a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512354014","title":"Calcimedica, Inc.盘中异动 急速拉升7.00%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512354014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512354014?lang=zh_cn&edition=full","pubTime":"2025-02-20 03:18","pubTimestamp":1739992731,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日03时18分，Calcimedica, Inc.股票出现波动，股价大幅上涨7.00%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为681.98%、255.20%、230.04%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.，振幅分别为280.70%、267.43%、159.49%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220031851abd531e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220031851abd531e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512199226","title":"Calcimedica, Inc.盘中异动 下午盘股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512199226?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:37","pubTimestamp":1739907442,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时37分，Calcimedica, Inc.股票出现波动，股价快速拉升5.57%。Calcimedica, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Aditxt, Inc.、Allogene Therapeutics, Inc.、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为864.59%、211.10%、169.99%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190337229627c84f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190337229627c84f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511195256","title":"Calcimedica, Inc.盘中异动 下午盘股价大跌5.62%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511195256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511195256?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:04","pubTimestamp":1739559847,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时04分，Calcimedica, Inc.股票出现波动，股价大幅跳水5.62%。截至发稿，该股报2.52美元/股，成交量1.4137万股，换手率0.10%，振幅4.87%。Calcimedica, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Calcimedica, Inc.公司简介：CalciMedica Inc 是一家临床阶段的生物制药公司，专注于开发治疗具有高度未满足需求的危及生命的炎症性疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150304079885c6c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150304079885c6c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CALC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://calcimedica.com;ir.calcimedica.com","stockEarnings":[{"period":"1week","weight":-0.1346},{"period":"1month","weight":-0.0605},{"period":"3month","weight":0.3825},{"period":"6month","weight":-0.8462},{"period":"1year","weight":-0.434},{"period":"ytd","weight":-0.8634}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0084},{"period":"3month","weight":0.0963},{"period":"6month","weight":0.074},{"period":"1year","weight":0.2016},{"period":"ytd","weight":0.0931}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CalciMedica, Inc.于2015年2月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发治疗由炎症和免疫过程以及直接细胞损伤驱动的严重疾病的疗法。公司候选产品作用于钙释放活化钙（“CRAC”）通道，将构成一类新药。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.093409},{"month":2,"riseRate":0,"avgChangeRate":-0.254297},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.215568},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.035007},{"month":5,"riseRate":0.5,"avgChangeRate":0.045995},{"month":6,"riseRate":0.666667,"avgChangeRate":0.093032},{"month":7,"riseRate":0.333333,"avgChangeRate":0.095263},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05924},{"month":9,"riseRate":0.4,"avgChangeRate":-0.051303},{"month":10,"riseRate":0.4,"avgChangeRate":-0.031218},{"month":11,"riseRate":0.5,"avgChangeRate":0.215716},{"month":12,"riseRate":0.5,"avgChangeRate":-0.013468}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CALCIMEDICA(CALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CALCIMEDICA(CALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}